Gilles Paintaud

Gilles Paintaud

UNVERIFIED PROFILE

Are you Gilles Paintaud?   Register this Author

Register author
Gilles Paintaud

Gilles Paintaud

Publications by authors named "Gilles Paintaud"

Are you Gilles Paintaud?   Register this Author

99Publications

2619Reads

24Profile Views

Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets.

Pulm Pharmacol Ther 2019 Aug 15;57:101807. Epub 2019 May 15.

CHRU de Tours, Médecine Intensive Réanimation, INSERM CIC 1415, CRICS-Triggersep, Tours, France; Université de Tours, INSERM, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, Tours, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10945539183010
Publisher Site
http://dx.doi.org/10.1016/j.pupt.2019.101807DOI Listing
August 2019

Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review.

Clin Pharmacokinet 2019 Aug 26. Epub 2019 Aug 26.

Department of Medical Pharmacology, Tours University Hospital, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-019-00816-7DOI Listing
August 2019

CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.

Br J Clin Pharmacol 2019 Aug 27. Epub 2019 Aug 27.

Université de Tours, EA 7501 GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.14102DOI Listing
August 2019

In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration.

J Control Release 2019 Jun 11;303:24-33. Epub 2019 Apr 11.

INSERM, Centre d'Etude des Pathologies Respiratoires, U1100, F-37032 Tours, France; Université de Tours, F-37032 Tours, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2019.04.005DOI Listing
June 2019

Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans.

Clin Pharmacokinet 2019 Feb;58(2):169-187

Université de Tours, EA7501 GICC, Team PATCH, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-018-0680-3DOI Listing
February 2019

Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.

J Pediatr 2019 01 9;204:225-233.e8. Epub 2018 Oct 9.

Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; CHRU de Tours, Service de Pharmacologie Clinique, Tours, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223476183097
Publisher Site
http://dx.doi.org/10.1016/j.jpeds.2018.07.065DOI Listing
January 2019

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Clin Pharmacokinet 2018 09;57(9):1173-1184

Laboratory of Pharmacology-Toxicology, Université François-Rabelais de Tours, CNRS, UMR 7292, CHRU de Tours, 2 Boulevard Tonnellé, 37044, Tours Cedex, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-017-0621-6
Publisher Site
http://dx.doi.org/10.1007/s40262-017-0621-6DOI Listing
September 2018

Modeling Immunization To Infliximab in Children With Crohn's Disease Using Population Pharmacokinetics: A Pilot Study.

Inflamm Bowel Dis 2018 07;24(8):1745-1754

Laboratory of Pharmacology-Toxicology, CNRS, GICC UMR 7292, Tours University Hospital, François-Rabelais University of Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy129DOI Listing
July 2018

A novel way to manage trastuzumab cardiotoxicity.

Cancer Chemother Pharmacol 2018 04 1;81(4):791-796. Epub 2018 Mar 1.

INSERM, U1165, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3555-2DOI Listing
April 2018

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

Clin Colorectal Cancer 2018 03 28;17(1):e109-e113. Epub 2017 Oct 28.

CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2017.10.003DOI Listing
March 2018

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab.

Eur J Cancer 2018 03 9;92:119-120. Epub 2018 Jan 9.

Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.004DOI Listing
March 2018

Development and validation of an ELISA to study panitumumab pharmacokinetics.

Bioanalysis 2018 Feb 18;10(4):205-214. Epub 2018 Jan 18.

Université François Rabelais de Tours, CNRS UMR 7292 GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2016-0292DOI Listing
February 2018

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis.

Ther Drug Monit 2017 08;39(4):360-363

*Rheumatology Department and Pharmacology-Toxicology Laboratory, Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France; and †Rheumatology Department and Health Research Institute (Idipaz), Hospital Universitario de La Paz, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000400DOI Listing
August 2017

Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases.

Ther Drug Monit 2017 08;39(4):339-343

*Université François-Rabelais de Tours, CNRS UMR 7292, Tours, France; †Unit of Pharmacology-Toxicology, University Hospital, Tours, France; ‡Neurologia 2, Centro Riferimento Regionale Sclerosi Multipla (CReSM), Orbassano, Turin, Italy; §Neuroscience Institute Cavalieri Ottolenghi (NICO), San Luigi Hospital, Orbassano, Turin, Italy; ¶Department of Clinical Pharmacology, Tours University Hospital, Tours, France; ∥Unit of Immunology, La Paz University Hospital, Madrid, Spain; and ††Department of Rheumatology, Tours University Hospital, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000410DOI Listing
August 2017

Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.

Ther Drug Monit 2017 08;39(4):316-321

*Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France; †Unit of Pharmacology-Toxicology, CHRU de Tours, Tours, France; ‡Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; §Department of Biochemistry and Genetics, Université d'Angers, Angers, France; ¶Department of Immunology, CHRU de Tours, Tours, France; and ‖Biologicals Lab, Sanquin Diagnostic Services, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000419DOI Listing
August 2017

Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling.

Ther Drug Monit 2017 08;39(4):322-326

*Université François-Rabelais de Tours, faculté de Médecine, France;†CNRS UMR 7292 GICC, Tours, France;‡Amsterdam Rheumatology Immunology Center, Reade;§Sanquin Research, Department of Immunopathology, Amsterdam, the Netherlands; and¶Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000389DOI Listing
August 2017

Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum.

Bioanalysis 2017 Aug 2;9(16):1227-1235. Epub 2017 Aug 2.

Université François Rabelais de Tours, CNRS UMR 7292 GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2017-0070DOI Listing
August 2017

Concentration-Response Relationship of Hearing Impairment Caused by Quinine and Salicylate: Pharmacological Similarities but Different Molecular Mechanisms.

Basic Clin Pharmacol Toxicol 2017 Jan 29;120(1):5-13. Epub 2016 Sep 29.

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.12640DOI Listing
January 2017

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis.

Arthritis Rheumatol 2017 01 28;69(1):108-113. Epub 2016 Nov 28.

Université François-Rabelais, CNRS, Genetics, Immunotherapy, Chemistry and Cancer UMR 7292 and CHRU de Tours, Service de Rhumatologie, Hôpital Trousseau, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39841DOI Listing
January 2017

Gota et al. on their article "the pharmacokinetics of Reditux™, a biosimilar of rituximab".

Cancer Chemother Pharmacol 2016 12 17;78(6):1317-1318. Epub 2016 Oct 17.

CNRS, GICC UMR 7292, Université François-Rabelais de Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3176-6DOI Listing
December 2016

The underlying inflammatory chronic disease influences infliximab pharmacokinetics.

MAbs 2016 10 9;8(7):1407-1416. Epub 2016 Aug 9.

a Université François Rabelais de Tours, CNRS, UMR, "Genetics, Immunotherapy, Chemistry and Cancer ," Tours , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19420862.2016.1216741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058621PMC
October 2016

Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.

Ther Drug Monit 2016 10;38(5):567-72

*Université François-Rabelais de Tours; †Service de Radiothérapie, CHRU de Tours; and ‡Laboratoire de Pharmacologie-Toxicologie, CHRU de Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000321DOI Listing
October 2016

[Not Available].

Therapie 2012 Jul-Aug;67(4):319-27

Afssaps, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2012043DOI Listing
July 2016

Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer.

J Clin Oncol 2016 06 29;34(16):e151-5. Epub 2014 Dec 29.

Université Paris Diderot, Unité Mixte de Recherche S728; Institut National de la Santé et de la Recherche Médicale U728; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.44.8894
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.44.8894DOI Listing
June 2016

[In Process Citation].

Therapie 2012 Jul-Aug;67(4):319-27. Epub 2012 Nov 1.

Université François Rabelais Tours ; CNRS UMR 7292 ; CHRU de Tours, Laboratoire de Pharmacologie-Toxicologie, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2012043DOI Listing
April 2016

Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety.

Therapie 2012 Jul-Aug;67(4):329-37. Epub 2012 Nov 1.

François Rabelais University Tours; CNRS UMR 7292; CHRU of Tours, Pharmacology-Toxicology Laboratory, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2012046DOI Listing
April 2016

CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.

Transpl Int 2016 Feb 8;29(2):184-95. Epub 2015 Oct 8.

Department of Nephrology and Clinical Immunology, Bretonneau Hospital, CHRU de Tours, EA4245, Université François-Rabelais de Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.12688DOI Listing
February 2016

A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS).

Eur J Clin Pharmacol 2016 Feb 31;72(2):253-5. Epub 2015 Oct 31.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-015-1973-1DOI Listing
February 2016

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding.

J Immunol 2016 Jan 18;196(2):607-13. Epub 2015 Dec 18.

Université François Rabelais de Tours, CNRS UMR7292, Tours F-37032, France; Laboratoire d'Immunologie, Centre Hospitalier Régional Universitaire de Tours, Tours F-37032, France; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1501780DOI Listing
January 2016

A robust estimation of infliximab pharmacokinetic parameters in Crohn's disease.

Eur J Clin Pharmacol 2015 Dec 15;71(12):1541-2. Epub 2015 Sep 15.

Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-015-1942-8DOI Listing
December 2015

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.

Clin Pharmacokinet 2015 Nov;54(11):1107-23

Laboratory of Pharmacology-Toxicology, Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, 2 Boulevard Tonnellé, 37044, Tours Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-015-0296-9DOI Listing
November 2015

F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study.

Joint Bone Spine 2015 Oct 13;82(5):381-3. Epub 2015 Mar 13.

Université François-Rabelais de Tours, 3, rue des Tanneurs, 37041 Tours cedex 1, France; CNRS UMR 7292, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Service de rhumatologie, CHRU de Tours, avenue de la République, 37044 Tours cedex 9, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2015.01.014DOI Listing
October 2015

Pharmacokinetics of adalimumab in Crohn's disease.

Eur J Clin Pharmacol 2015 Sep 27;71(9):1155-7. Epub 2015 Jun 27.

Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-015-1892-1DOI Listing
September 2015

Serum infliximab concentrations in psoriatic patients treated with infliximab: a systematic review.

Acta Derm Venereol 2015 Apr;95(4):401-6

Department of Dermatology, University Hospital of Tours, University François Rabelais, FR-37000 Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-1980DOI Listing
April 2015

Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis.

Br J Clin Pharmacol 2015 Feb;79(2):286-97

CNRS, UMR 7292, 'Genetics, Immunotherapy, Chemistry and Cancer', Université François Rabelais de Tours, Tours, France; Laboratoire de pharmacologie-toxicologie, CHRU de Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309634PMC
February 2015

Lung and serum teicoplanin concentration after aerosol and intravenous administration in a rat model.

J Aerosol Med Pulm Drug Deliv 2014 Aug 9;27(4):306-12. Epub 2013 Dec 9.

1 Université François Rabelais , EA 6305, F-37032 Tours, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jamp.2013.1060DOI Listing
August 2014

Towards an individualised target concentration of adalimumab in rheumatoid arthritis.

Ann Rheum Dis 2014 Jul 18;73(7):1428-9. Epub 2014 Feb 18.

Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Service de Rhumatologie, CHRU de Tours, Tours, France.

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2013-20497
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2013-204971DOI Listing
July 2014

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.

Inflamm Bowel Dis 2014 Jun;20(6):978-86

1Sorbonne Universités - UPMC Univ Paris 06, INSERM ERL 1157, CNRS UMR 7203 LBM and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), CHU Saint-Antoine, Paris, France; 2Centre Hospitalier Universitaire de Liège, Liège, Belgium; 3Université Lille Nord de France and CHRU Lille, Lille, France; 4Hôpital Nord, Centre d'investigation clinique Marseille Nord, Université Méditerranée, Marseille, France; 5INSERM U853, Hôpital Beaujon, Université Paris Diderot, Paris, Clichy, France; 6Université Bordeaux, Bordeaux, France; 7Hôpital Nord, Amiens, France; 8Hôpital Henri Mondor, Créteil, France; 9Hôpital Trousseau, Tours, France; 10Hôpital Saint-Eloi, Montpellier, France; 11Hôtel Dieu, Nantes, France; 12Hôpital Charles Nicolle, Université de Rouen, Rouen, France; 13Hôpital Européen Georges Pompidou, Paris, France; 14University of Ghent, Ghent, Belgium; 15Université François Rabelais de Tours, Tours, France; 16Hôpital Saint-Louis, Université Paris Diderot, Paris, France; 17INSERM U717, Biostatistics and clinical epidemiology, Université Paris Diderot, Paris, France; and 18Icahn Medical School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000036DOI Listing
June 2014

Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients.

Pharmacogenet Genomics 2014 Jan;24(1):26-34

aFrançois Rabelais University of Tours bCNRS, UMR 7292 'GICC' University of Tours cLaboratory of Pharmacology-Toxicology, University Hospital of Tours dLaboratory of Immunology eDepartment of Nephrology and Clinical Immunology, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000017DOI Listing
January 2014

Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases.

J Am Acad Dermatol 2013 Oct;69(4):649-50

Université François Rabelais de Tours, Tours, France; Service de Dermatologie, CHU de Tours, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.04.032DOI Listing
October 2013

Influence of plasma exchange on rituximab pharmacokinetics.

Br J Clin Pharmacol 2013 Sep;76(3):486-8

CNRS, UMR 7292, France; Université François-Rabelais de Tours, PRES Centre-Val de Loire Université, GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769676PMC
September 2013

Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma.

Br J Clin Pharmacol 2012 Apr;73(4):597-605

Université François Rabelais de Tours, Laboratoire de Pharmacologie-Toxicologie, CHRU Tours, 2 boulevard Tonnellé, Tours Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2125.2011.04125.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376436PMC
April 2012

Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label study.

Ther Drug Monit 2011 Aug;33(4):411-6

Université François Rabelais de Tours, Centre National de la Recherche Scientifique UMR 6239 Génétique Immunothérapie Chimie et Cancer, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e318224f83dDOI Listing
August 2011

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study.

Arthritis Res Ther 2011 Jun 3;13(3):R82. Epub 2011 Jun 3.

Université François-Rabelais de Tours, Centre National de la Recherche Scientifique UMR 6239 GICC, 3 rue des Tanneurs, F-37041 Tours Cedex 1, France.

View Article

Download full-text PDF

Source
http://arthritis-research.biomedcentral.com/articles/10.1186
Publisher Site
http://dx.doi.org/10.1186/ar3350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218893PMC
June 2011

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases.

Arthritis Res Ther 2011 Jun 27;13(3):R105. Epub 2011 Jun 27.

Université François Rabelais de Tours, Centre National de la Recherche Scientifique UMR 6239 GICC, 3 rue des Tanneurs, F-37041 Tours Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar3386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218920PMC
June 2011

An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics.

Ther Drug Monit 2010 Oct;32(5):647-52

Université François Rabelais de Tours, Genetics, Immunotherapy, Chemistry and Cancer, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e3181ef582aDOI Listing
October 2010

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis.

Arthritis Res Ther 2009 25;11(6):R178. Epub 2009 Nov 25.

Université François-Rabelais de Tours, 3 rue des Tanneurs, 37041 Tours Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar2867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003525PMC
May 2010

[Pharmacokinetics (PK) of mAbs].

Authors:
Gilles Paintaud

Med Sci (Paris) 2009 Dec;25(12):1057-62

Université François Rabelais de Tours, < Génétique, immunothérapie, chimie et cancer >, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/200925121057DOI Listing
December 2009

[Monoclonals antibodies: a recent and major therapeutic advance].

Therapie 2009 Jan-Feb;64(1):1-7. Epub 2009 May 26.

Université François-Rabelais de Tours, GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2009008DOI Listing
September 2009

Infliximab pharmacokinetics in inflammatory bowel disease patients.

Ther Drug Monit 2008 Aug;30(4):523-9

Université François Rabelais Tours, GICC, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e318180e300DOI Listing
August 2008

Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.

Intensive Care Med 2008 Apr 29;34(4):755-62. Epub 2007 Nov 29.

Service de réanimation médicale polyvalente, Centre hospitalier universitaire de Tours, 37044, Tours cedex 9, France.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs00134-007-09
Web Search
http://link.springer.com/10.1007/s00134-007-0935-1
Publisher Site
http://dx.doi.org/10.1007/s00134-007-0935-1DOI Listing
April 2008

[Target antigens for therapeutic antibodies in oncology: many candidates, few successes].

Bull Cancer 2007 ;94(7 Suppl):F129-36

EA 3853 Immuno-pharmaco-génétique des anticorps thérapeutiques, Université François Rabelais, Faculté de Médecine, 10 boulevard Tonnellé, BP 3223, 37032 Tours Cedex 1.

View Article

Download full-text PDF

Source
December 2007

Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?

Arthritis Rheum 2007 Dec;56(12):3887-95

François Rabelais de Tours University, EA 3853 Immuno-Pharmaco-Génétique des Anticorps thérapeutiques, Tours Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23051DOI Listing
December 2007

Biotherapies: are they just like any other drugs?

Therapie 2007 May-Jun;62(3):229-39. Epub 2007 Sep 6.

Université François Rabelais Tours, EA 3853, CHRU de Tours, Pharmacologie, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie:2007041DOI Listing
November 2007